NCT05770700 (STIM-RENASED) is a clinical trial in Chronic Pain, sponsored by Sociedad Espanola del Dolor.

Who is sponsoring NCT05770700?

NCT05770700 is sponsored by Sociedad Espanola del Dolor.

What condition does NCT05770700 study?

NCT05770700 studies Chronic Pain.

Is NCT05770700 still recruiting?

NCT05770700 is currently recruiting now. Last updated 22 May 2024.

Last reviewed 2024-05-22 · How we verify

NCT05770700: STIM-RENASED

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness and Safety of Implantable Neurostimulation Systems for Chronic Pain: A Spanish Multicenter Study (STIM-RENASED)

Recruiting now Last updated 22 May 2024

What this trial tests

trial in Chronic Pain in 504 participants. Currently enrolling.

Timeline

1 April 2023

Primary endpoint
1 April 2025

1 April 2025

Quick facts

Lead sponsor	Sociedad Espanola del Dolor
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	504
Start date	1 April 2023
Primary completion	1 April 2025
Estimated completion	1 April 2025
Sites	16 locations across Spain

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

Sociedad Espanola del Dolor

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic pain is a prevalent condition that negatively affects patients' quality of life. Implantable neurostimulation therapies have been proposed as a treatment option for chronic pain. However, real-world data on the effectiveness and safety of these therapies in Spain are scarce. This study aims to obtain real-world data on the effectiveness and safety of implantable stimulation systems for chronic pain treatment in Spain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other Sociedad Espanola del Dolor trials

Trials by the same sponsor.

NCT05970081 — Effectiveness and Safety of Implantable Intrathecal Systems for Refractory Pain in Spain (INTRATHECAL-RENASED) · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05770700 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sociedad Espanola del Dolor
Last refreshed: 22 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05770700.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing